REGISTER FOR THIS LIVE WEBINAR!
Description: Approaches to calculating, reporting, and interpreting Tumor Mutational Burden (TMB) testing will be discussed in this second of two updates on the broader use of TMB as a potentially prognostic and predictive tool in clinical care. Dr. Stenzinger will provide an overview of how large-scale efforts to harmonize TMB measurement may bolster the potential clinical utility of TMB reporting.
Duration: 1 hr
Level of Instruction: Basic
This webinar is part 2 of a two-part series exploring the role of TMB testing in relationship to other tumor biomarkers as well as the standardization of TMB testing.
This program has been supported through an educational grant from Bristol-Myers Squibb.
August 15, 2019 11:00 AM Eastern
AMP Regular Member Price:
AMP Technologist Member Price:
AMP Associate Member Price: